Clinical Trial Update: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating inhaled tobramycin for eradication of Pseudomonas aeruginosa in adults with bronchiectasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Tobramycin Inhalation Solution (tobramycin inhalation solution)

Snippet

Sponsor: Jin-Fu Xu | Conditions: Bronchiectasis Adult, Pseudomonas Aeruginosa Infection | Phase 4 | Status: COMPLETED